Worldwide Non-opioid Pain Treatment Market Insights, 2018-2019 & 2024, with Comprehensive Profilings of Allergan, Canopy Growth Corp, Medical Marijuana, Panag Pharma, Tilray, and More

News provided by

Jan 10, 2020, 08:15 ET

DUBLIN, Jan. 10, 2020 /PRNewswire/ -- The "Non-opioid Pain Treatment: Global Markets to 2024" report has been added to ResearchAndMarkets.com's offering.

This report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management.

The geographical scope of this study is global. This study addresses acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies five general product segments for Non-opioid treatment of pain:

Medical cannabis treatments
Capsaicin-derived treatments
Menthol-containing treatments
Omega 3 fatty acid-containing treatments
Botulinum toxins

Within the segment, several sub-segments are discussed as they pertain to each product segment; diseases or disorders are the basis for these sub-segments, including:

Arthritis
Cancer-brain, breast, colorectal, leukemia/lymphoma, melanoma, prostate, others
Dental
Epilepsy
Fibromyalgia
Migraine
Multiple sclerosis
Surgical

Each market segment provides detailed information based on product categories, product use, current market value and forecasts.

Report Scope

An overview of the global market for Non-opioid pain treatments
Analyses of global market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
Description of products included in this market, and a detailed analysis of the markets and market opportunities
Information on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the pain management industry
Briefing about major drivers and regional dynamics of the market and current trends within the industry
Comprehensive profiles of major vendors in the market, including Allergan, Canopy Growth Corp, Medical Marijuana, Panag Pharma, and Tilray

Key Topics Covered

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown

Chapter 2 Summary and Highlights

Market Overview
Drivers and Restraints

Chapter 3 Market Overview and Background

Definition of Pain and Nociception
Pain
Nociception
History of Pain and Pain Treatment
Types of Pain
Acute Pain
Chronic Pain
Physiological Pain Classifications
How Pain is Diagnosed
How Pain is Treated
Opioid vs. Non-opioid Pain Control
Opioids, also Known as Narcotic Analgesics
Full and Partial Agonists
Agonist-Antagonists
Risk and Complications in Opioid Pain Treatment
Addiction and Abuse
Challenges of Breakthrough Pain Control
Alternative Methods of Pain Management
Alternative Non-opioid Therapies for Treating Pain
Medical Cannabis
Capsaicin-derived Compound
Menthol-containing Compound
Omega 3 Fatty Acid-containing Supplements
Botulinum Toxins (OnabotulinumtoxinA/RimabotulinumtoxinB)
Others
Growing Trend in Cannabis Treatment for Pain
Adoption of Medical Cannabis: A Global Analysis
Laws and Legalization Trends
Claims in Effectiveness
Potency and Validation Testing Trends
Hospice Care
Access to Palliative Care Around the World
Assessing the Need for Palliative Care
Market Influences and Indicators of Growth
Demographic Overview
Incidence and Prevalence of Conditions with Pain Symptoms

Chapter 4 Market Breakdown by Product Segment

Overview
Medical Cannabis
Capsaicin-derived Therapies
Menthol-containing Therapies
Omega-3 Fatty Acid-containing Therapies
Botulinum Toxin Treatments

Chapter 5 Market Breakdown by Therapeutic Application

Overview
Alternative Non-opioid Cancer Pain Treatment
Alternative Non-opioid Neuropathic Pain Treatment
Alternative Non-opioid Orthopedic/Musculoskeletal Pain Treatments
Other Alternative Non-Opioid Pain Treatments

Chapter 6 Market Breakdown by Region

Overview
Regional Groupings
North America
North America: Pioneer in the Medicinal Cannabis Industry
Canada
United States
EMEA
France
Germany
Italy
Russia
Spain
United Kingdom
Asia-Pacific
Australia/New Zealand
China
Japan
Latin America
Argentina
Brazil
Mexico

Chapter 7 Patent Analysis

Patent Analysis Overview
Non-opioid Pain Relief Categories
Medical Cannabis
Technologies
Cannabis Patent Review by Year
Patent Review by Company
Patent Review by Assignee

Chapter 8 Company Profiles

Allergan PLC
Aphria Inc.
Aurora
Bedrocan
Canopy Growth Corp.
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medical Marijuana Inc.
Medropharm GmbH
Panag Pharma Inc.
Tilray
US Worldmeds LLC
Vanway

For more information about this report visit https://www.researchandmarkets.com/r/j5g0un

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets